Leni Tesamorelin — 6-pack studio product image

Tesamorelin — 6-pack

Body composition, with the details included.

Tesamorelin is a growth hormone-releasing hormone analogue. Its defining feature is the signalling pathway it acts on, with a specialist body-composition context in medicine. There’s a little more to this one than a broad “weight loss” label. This pack contains 6 vials of the same listed product.

$966.60 AUD

$1,074.00 bought separatelySave $107.40 · 10%$161.10 per item
Pack quantity
6 items
Presentation
Vial
The details
Specifications pending confirmation

Choose your pack

How would you like it?

Preview bag only · No orders or payments

↗ Tracked delivery♡ Free standard shipping from $100

Let’s get acquainted.

The useful bits. The finer points.
The questions you were about to Google.

The useful bits, up front.

  • GHRH analogue. Related to the hormone that signals the pituitary gland to release growth hormone.
  • Growth-hormone pathway. Studied in connection with growth-hormone and IGF-1 responses.
  • Specialist body-composition context. Medicine evidence concerns excess abdominal fat in adults with HIV-associated lipodystrophy.

A little more of the story.

Hormone signalling is a chain of messages. Tesamorelin acts at a point in that chain associated with growth-hormone release. A specific US medicine uses it for a defined clinical indication involving abnormal fat distribution in people with HIV. That background gives the molecule its place in body-composition discussions. Keeping that context attached makes the story much more useful.

What’s in the 6-pack?

6 × Tesamorelin — proposed 10 mg per vial. The 6-pack brings the same listed product together in one selection. The compound story stays the same across every size; only the quantity changes.

Pack quantity counts items, not doses or a recommended course. The proposed amount is total vial content, not a concentration or suggested dose.

Good to know.

The referenced medicine is not indicated for general weight-loss management. This proposed vial is not identified as Egrifta or established as equivalent to it. Safety, suitability and current-batch specifications remain product-specific questions.

The finer points.
Product details
Product Tesamorelin
Pack contents 6 vials
Presentation Vial
Proposed content per vial 10 mg — supplier confirmation pending
Formulation and fill details Product-specific confirmation pending
Batch, manufacturer and expiry Current-batch details pending
Identity, content and purity Current-batch verification pending
Storage and stability Product-specific information pending
Sterility and endotoxin Not verified
Is this a general weight-loss product?

The cited medicine label explicitly distinguishes its specialist indication from general weight-loss management.

Is this the same as growth hormone?

Tesamorelin is an analogue of a hormone that signals growth-hormone release; it is not growth hormone itself.

Explore the source material.

These references describe research or specific medicines. They do not verify the contents or performance of this catalogue product.

Explore the single Tesamorelin listing →